Clinical Trial Update: Docetaxel and Carboplatin Followed by Oral Capecitabine, Docetaxel and Radiation for Esophageal Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial evaluating a multi-drug regimen for esophageal cancer has completed the study. The regimen includes docetaxel and carboplatin followed by oral c…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• Capecitabine (capecitabine)
• DOCETAXEL (DOCETAXEL)

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Esophageal Neoplasms | Phase 1 | Status: COMPLETED